Kenneth Bloom
Strategic Advisor 1Cell.Ai
Seminars
Tuesday 4th November 2025
Multi-Omic Assessment of Circulating Tumor Cells to Optimize ADC Therapies
3:30 pm
- Understanding the relationship between CTC analysis and disease state
- Demonstrating how characterizing CTCs can guide the selection of the most effective ADC therapy
- Showing how serial CTC analysis can identify early resistance to ADC therapy by tracking changes in count and phenotype
- Exploring the discordance between CTC and tissue antigen evaluation
